Authors
Loading...
Retrospective analysis examines cardiotoxicity incidence in ibrutinib patients, suggesting manageable risks related to atrial fibrillation and hypertension.
Carvalheiro et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: